Back
Celldex Therapeutics Stock Price Chart
The Fed Just Cut Rates-Here's Alex Green's $1 Million AI Stock Picks
Watch Alex Green's breakdown and discover the next big AI winners!
Sell
37
CLDX
Celldex Therapeutics
Last Price:
32.87
Seasonality Move:
1.08%
7 Day Trial
ALL ACCESS PASS
$
7
Invest in This AI Tech Innovator Doubling Revenue
Invest Now!- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CLDX is experiencing slight selling pressure.
Celldex Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 40.69 | Sell |
| 20-day SMA: | 41.52 | Sell |
| 50-day SMA: | 38.47 | Sell |
| 200-day SMA: | 38.87 | Sell |
| 8-day EMA: | 40.13 | Sell |
| 20-day EMA: | 40.37 | Sell |
| 50-day EMA: | 39.15 | Sell |
| 200-day EMA: | 37.62 | Sell |
Celldex Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.42 | Buy |
| Relative Strength Index (14 RSI): | 37.46 | Sell |
| Chaikin Money Flow: | -2311480 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (38.03 - 43.15) | Sell |
| Bollinger Bands (100): | (34.54 - 41.04) | Sell |
Celldex Therapeutics Technical Analysis
| Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | Sep 23 | Sep 24 | Sep 25 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 12 | 13 | 16 | 17 | 18 | 19 | 20 | 23 | 24 | 25 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Celldex Therapeutics Stock
Is Celldex Therapeutics Stock a Buy?
- Celldex Therapeutics share price is 36.02 while CLDX 8-day simple moving average is 40.69, which is a Sell signal.
- The stock price of CLDX is 36.02 while Celldex Therapeutics 20-day SMA is 41.52, which makes it a Sell.
- Celldex Therapeutics 50-day simple moving average is 38.47 while CLDX share price is 36.02, making it a Sell technically.
- CLDX stock price is 36.02 and Celldex Therapeutics 200-day simple moving average is 38.87, creating a Sell signal.
CLDX Technical Analysis vs Fundamental Analysis
Sell
37
Celldex Therapeutics (CLDX)
is a Sell
Is Celldex Therapeutics a Buy or a Sell?
-
Celldex Therapeutics stock is rated a Sell
The current Celldex Therapeutics [CLDX] share price is $36.02. The Score for CLDX is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
Celldex Therapeutics Stock Info
Market Cap:
2.39B
Price in USD:
36.02
Share Volume:
12.32M
Celldex Therapeutics 52-Week Range
52-Week High:
53.18
52-Week Low:
22.11
Sell
37
Celldex Therapeutics (CLDX)
is a Sell
Celldex Therapeutics Share Price Forecast
-
What is the Celldex Therapeutics stock price today?
The Celldex Therapeutics stock price is 36.02 USD today. -
Will CLDX stock go up or go down?
Celldex Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Celldex Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Celldex Therapeutics is overvalued.
Is Celldex Therapeutics Stock a Buy?
- Celldex Therapeutics share price is 36.02 while CLDX 8-day exponential moving average is 40.13, which is a Sell signal.
- The stock price of CLDX is 36.02 while Celldex Therapeutics 20-day EMA is 40.37, which makes it a Sell.
- Celldex Therapeutics 50-day exponential moving average is 39.15 while CLDX share price is 36.02, making it a Sell technically.
- CLDX stock price is 36.02 and Celldex Therapeutics 200-day simple moving average is 37.62, creating a Sell signal.
Fundamental Analysis of Celldex Therapeutics
Is Celldex Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $0.03 per share, a decrease next quarter of $0.18 per share, an increase this year of $0.19 per share, and a decrease next year of $0.66 per share.
Technical Analysis of Celldex Therapeutics
Should I short Celldex Therapeutics stock?
- CLDX Moving Average Covergence Divergence (MACD) indicator is 0.42, suggesting Celldex Therapeutics is a Buy
- Celldex Therapeutics Relative Strength Index (RSI) is 37.46, which suggest Celldex Therapeutics is oversold
- The Bollinger Bands (25) for Celldex Therapeutics is (38.03 - 43.15), which suggest Celldex Therapeutics is a Sell
- The Bollinger Bands (100) for Celldex Therapeutics is (34.54 - 41.04), which suggest Celldex Therapeutics is a Sell
* Celldex Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.